ALI ASIF (Chief Financial Officer) received a stock award from PROTAGONIST THERAPEUTICS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2026ACC: 0001104659-26-001472
Officer· Chief Financial Officer
Since Apr 2022
+57.60K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
57.60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25.60K
Price / share
—
Trade value
—
% of position
41.9%
1/2/2026
61.06K→86.67K
Total
Net shares
+25.60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +25.60K | — | — | 41.9% | 61.06K | 86.67K |
| Total | +25.60K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
32K shares
Shares
+32K
Strike price
87.18
Held after
32K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock32K shares | 1/2/2026 | A · Award | +32K | 87.18 | — | 32K |